Plain language summary of the EMPEROR-Preserved study looking at the effect of empagliflozin in patients with heart failure with preserved ejection fraction, with and without diabetes
Future Cardiology, Ahead of Print.
Source: Future Cardiology - Category: Cardiology Authors: Javed Butler Gerasimos Filippatos Source Type: research
More News: Cardiology | Diabetes | Empagliflozin | Endocrinology | Heart | Heart Failure | Jardiance | Study